European Partnership on Rare Diseases (ERDERA) (Phase 2) vs Latvia – Reagents and contrast media – Imūnhistoķīmijas antivielas un reaģenti kopā ar iekārtām Patoloģijas centram
Side-by-side comparison of two grants.
| Attribute | European Partnership on Rare Diseases (ERDERA) (Phase 2) | Latvia – Reagents and contrast media – Imūnhistoķīmijas antivielas un reaģenti kopā ar iekārtām Patoloģijas centram |
|---|---|---|
| Type | Grant | Tender |
| Funding amount | $103.9M | — |
| Deadline | Closes 2026-09-15 | Closes 2026-08-21 |
| Region | EU | LVA |
| Sector | Health | Health |
| Funder | European Commission (HORIZON) | SIA „Rīgas Austrumu klīniskā universitātes slimnīca” |
| Who it's for | researchers | — |